Data / Form D filings / LQ3 Pharmaceuticals, Inc.
LQ3 Pharmaceuticals, Inc.: Form D filings
LQ3 Pharmaceuticals, Inc., a pharmaceuticals company in Morrisville, NC, filed 2 Form D notices with the SEC in 2014. The latest, on December 17, 2014, reports $2.4 million sold of a $10 million offering to 4 investors.
Find out what LQ3 Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 419 DAVIS DRIVE, SUITE 100, Morrisville, NC, 27560
- Phone
- (919) 328-4377
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2013
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1614268
The full lists. Form D filings in North Carolina: 984 rows, $49.20, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 17, 2014 | Amendment | $10,000,000 | $2,352,940 | $7,647,060 | 4 | Jul 10, 2014 | sec.gov |
| Jul 23, 2014 | New notice | $10,000,000 | $1,999,998 | $8,000,002 | 3 | Jul 10, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Neal Fowler | Director | |
| Seth Rudnick | Director | |
| Stephen Bloch | Director | |
| Tim Albury | Executive Officer | |
| Shawn Glidden | Executive Officer | |
| Kyle Chenet | Executive Officer, Director, Promoter |
Other pharmaceuticals companies in North Carolina that filed recently
- Dignify Therapeutics, LLC $800,000 · Sep 25, 2026
Every Form D from the week of Dec 15, 2014 · All recent filings in North Carolina · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what LQ3 Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.